Speaker Details

Brett Andrew King, MD, PhD, FAAD

Brett Andrew King, MD, PhD, FAAD

SESSIONS

S022 Alopecia Areata: New Therapies
Mar 8, 2024 • 1:00 PM - 4:00 PM • Room 20A
S025 JAK Inhibitors: A New Frontier in Dermatology
Mar 9, 2024 • 9:00 AM - 12:00 PM • Room 6B
S050 Late-Breaking Research: Session 2
Mar 10, 2024 • 1:00 PM - 4:00 PM • Room 20B
S057 Alopecia: Work-up and Treatment
Mar 11, 2024 • 9:00 AM - 12:00 PM • Room 6B
C018 Updates in Hair Disorders
Mar 11, 2024 • 1:00 PM - 4:00 PM • Room 23C

DISCLOSURES

AbbVie – Advisory Board(Honoraria), Speaker(Honoraria); AnaptysBio – Consultant(Fees), Investigator(Fees); Arena Pharmaceuticals – Consultant(Fees), Investigator(Fees); ASLAN Pharmaceuticals – Consultant (1099 relationship)(Fees), Investigator(Fees); BiologicsMD, Inc. – Consultant(Stock Options); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees); Concert Pharmaceuticals – Consultant(Fees), Investigator(Fees); Eli Lilly and Company – Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Equillium, Inc. – Consultant(Fees); Horizon Pharma, Inc. – Consultant(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Fees), Data Safety Monitoring Board(Fees), Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Fees); Pfizer Inc. – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Investigator(Fees), Speaker(Honoraria); Q32 Bio Inc. – Consultant (1099 relationship)(Fees), Investigator(Fees); Regeneron – Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); TWi Biotechnology, Inc. – Consultant(Fees);